Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Andrew A. Krakauer currently holds 7,192.01 shares of CANTEL MEDICAL CORP (CMN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrew A. Krakauer has been a net seller of CMN stock. They have purchased $796.4K and sold $9.7M worth of shares.
Andrew A. Krakauer's most recent insider trade was on Aug 5, 2025, when they purchased 1,000 shares at $115.25 per share.
Andrew A. Krakauer serves as Executive at CANTEL MEDICAL CORP (CMN). They have executed 100 insider transactions totaling $10.5M over their tenure at the company.
Andrew A. Krakauer holds the position of Executive at CANTEL MEDICAL CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Andrew A. Krakauer has shown a selling trading pattern, with $796.4K in total purchases and $9.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Andrew A. Krakauer was on Oct 14, 2015, when they sold $1.2M worth of CMN shares. This transaction involved 22,981 shares at $54.22 per share.
Andrew A. Krakauer currently owns 7,192.01 shares of CANTEL MEDICAL CORP (CMN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Andrew A. Krakauer's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Andrew A. Krakauer has 100 Form 4 filings on record as an insider at CANTEL MEDICAL CORP.
Set alerts for Andrew A. Krakauer and 40,000+ other insiders.